Agenus, Inc. (AGEN)
3.75
-0.14
(-3.60%)
USD |
NASDAQ |
May 07, 16:00
3.69
-0.06
(-1.60%)
After-Hours: 05:04
Agenus Research and Development Expense (Annual) : 79.34M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 52.79M |
| The Ensign Group, Inc. | -- |
| Protalix Biotherapeutics, Inc. | 19.05M |
| CervoMed, Inc. | 21.82M |
| Allogene Therapeutics, Inc. | 137.79M |